Selected as a finalist for the “CITELINE JAPAN AWARDS 2024.”

Nippon Shokubai has been selected as a finalist in the BEST CDMO category for the “CITELINE JAPAN AWARDS 2024” organized by Citeline !

This prestigious award honors outstanding advancements and innovations in Japanese pharma and biotech, serving as the Japanese counterpart to “Scrip Awards” which has been held for 19 years in the UK.